Thursday, July 9, 2026

pharma · Diabetic Kidney Disease · ZVSA

ZyVersa Therapeutics

ZyVersa Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Weston, USA HQ
2014 Founded
11 Employees
Public company Type
ZVSA · NYSE Ticker
Company details
Status
Public
HQ
Weston, USA
Founded
2014
Employees
11
Programs
1
Drugs
0
Patents
0
Intelligence · Clinical Programs

ZyVersa Therapeutics projects

1 ClinicalTrials.gov programs sponsored by ZyVersa Therapeutics.

ZyVersa Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 2HPβCD

    ZyVersa Therapeutics

    Diabetic Kidney Disease

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does ZyVersa Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.